Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children
Conditions: Voiding Disorders; Overactive Bladder Interventions: Drug: Beta3-Agonists, Adrenergic; Drug: Anticholinergic drug, Solifenacin Sponsor: Mansoura University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2022 Category: Research Source Type: clinical trials